Riskpilot← Back to searchSign inGet full accessFaris Medical AB
ABActiveOrg 5567017818Pipersgatan 5 A Lgh 1101General medical practice activities · NACE 8621Est. 20063 employees
Revenue 2024
SEK 3,8M
-1% vs 2023
EBITDA margin
26.4%
-9% vs 2023
Equity ratio
80.6%
Financial strength
Net profit 2024
SEK 1,3M
+46% vs 2023
| Revenue | SEK 3,8M | -1% |
| EBITDA | SEK 1M | -9% |
| Net profit | SEK 1,3M | +46% |
| Total assets | SEK 8,5M | +0% |
| Equity | SEK 6,8M | +11% |
| Employees | 3 | — |
Legal name
Faris Medical AB
Org number
5567017818
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 april 2006
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso- och sjukvård, konsultationer och utbildning inom medicinska frågor, friskvård och marknadsföring av medicinsk teknik samt därmed förenlig verksamhet.
Address
Pipersgatan 5 A Lgh 1101
Phone
+46739736450
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 533 | 3 958 | 3 925 | 3 853 | 3 826 |
| Staff expenses | — | — | — | — | −2 085 |
| EBITDA | 1 762 | 1 409 | 1 214 | 1 114 | 1 008 |
| Depreciation & amort. | −44 | −12 | −13 | −6 | −15 |
| EBIT | 1 718 | 1 397 | 1 201 | 1 108 | 993 |
| Net financials | — | 26 | 1 | 13 | 8 |
| Profit before tax | 1 471 | 1 543 | 902 | 1 179 | 1 711 |
| Tax | −321 | −325 | −190 | −262 | −373 |
| Net profit | 1 150 | 1 218 | 712 | 917 | 1 337 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 896 | 8 190 | 8 412 | 8 518 | 8 492 |
| Equity | 5 242 | 5 860 | 5 912 | 6 169 | 6 846 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 765 | 561 | 431 | 340 | 346 |
| Total debt | 765 | 561 | 431 | 340 | 346 |
EBITDA margin
26.4%
This company
15.8%
Market median
+67% vs market
20202024
Equity ratio
80.6%
This company
38.2%
Market median
+111% vs market
20202024
Return on equity
19.5%
This company
18.4%
Market median
+6% vs market
20202024
Net profit margin
35.0%
This company
8.1%
Market median
+332% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
FA Chief Executive Officer | Chief Executive Officer | 2022 |
BE | Audit | 2025 |
| Former (1) | ||
DE Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Faris Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Faris A Hamid Al Khalili | Chief Executive Officer | 0 companies |
| Barbro Elisabeth Lillkaas | Audit | 0 companies |
| Dick Erik Helén | Audit | 0 companies |
| Martin Sina Faris Al Khalili | Deputy Board Member | 0 companies |
| Jenan Jaafar | Deputy Board Member | 0 companies |